
==== Front
Am J Case Rep
Am J Case Rep
amjcaserep
The American Journal of Case Reports
1941-5923
International Scientific Literature, Inc.

39205369
10.12659/AJCR.943658
943658
Articles
Adult-Onset PFAPA Syndrome: Successful Management with Colchicine
Balagani Amulya B D E F 1 https://orcid.org/0000-0003-3710-9184

Tariq Farina E 2
Zaheer Muhammad C E F 1
1 Division of Rheumatology, Saint Louis University School of Medicine, Saint Louis, MO, USA
2 Department of Medicine, Quaid e Azam Medical College, Bahawalpur, Pakistan
Corresponding Author: Amulya Balagani, e-mail: amulyab2710@gmail.com
Authors’ Contribution:

A Study Design

B Data Collection

C Statistical Analysis

D Data Interpretation

E Manuscript Preparation

F Literature Search

G Funds Collection

Financial support: None declared

Conflict of interest: None declared

2024
29 8 2024
25 e943658-1e943658-3
31 12 2023
19 6 2024
22 7 2024
© Am J Case Rep, 2024
2024
https://creativecommons.org/licenses/by-nc-nd/4.0/ This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
Patient: Female, 22-year-old

Final Diagnosis: Periodic fever • aphthous stomatitis • pharyngitis • cervical adenitis (PFAPA) syndrome

Symptoms: Recurrent fevers associated with sore throat, enlarged painful cervical lymph nodes

Clinical Procedure: —

Specialty: Rheumatology

Objective:

Unusual clinical course

Background:

Periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome is an autoinflamma-tory fever syndrome primarily seen in children under age 5 years, and its etiology is unknown. Most cases are resolved by the age of 10 years, and it is rare in adults. PFAPA is characterized by recurrent episodes of fever associated with pharyngitis, stomatitis, and cervical adenitis, although not all clinical features are present at initial evaluation. Diagnosis is made clinically, as there are no specific biomarkers available. Treatment includes prednisone, colchicine, interleukin-1 blockers, and tonsillectomy. We report a case of adult-onset PFAPA syndrome that responded to colchicine.

Case Report:

A 22-year-old woman presented to the Rheumatology Clinic for evaluation of recurrent fevers associated with sore throat and enlarged painful cervical lymph nodes. She was symptom-free between the episodes. Workup for infectious causes and autoinflammatory/autoimmune diseases was unremarkable. Various differential diagnoses were considered, due to her unusual presentation. After all were ruled out, PFAPA was diagnosed based on her symptoms, and she started steroids, to which she had a dramatic response and resolution of symptoms. She was then transitioned to oral colchicine, which significantly decreased flare frequency.

Conclusions:

Being aware of PFAPA syndrome in adults is vital. A timely diagnosis can significantly improve a patient’s quality of life. This case highlights the importance of considering PFAPA syndrome in the differential diagnosis of periodic febrile illnesses in adults and the role of Colchicine as prophylaxis. Larger studies are needed to understand etiopathogenesis better and develop other effective therapeutics.

Keywords:

Steroids
Colchicine
Interleukin-1beta (204-215)
Periodic Fever, Familial, Autosomal Dominant
==== Body
pmcIntroduction

Periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome is an autoinflammatory fever syndrome mostly seen in children under 5 years of age and is rare in adults. It was initially called Marshall’s syndrome until the acronym PFAPA was proposed in 1989 [1]. The etiology of the disease is still unknown, and the diagnosis is made clinically [2]. There are some differences between adult and pediatric PFAPA patients. Treatment includes corticosteroids and tonsillectomy. We report a case of adult-onset PFAPA syndrome that responded to colchicine.

Case Report

A 22-year-old woman presented to the Rheumatology Clinic for evaluation of recurrent fevers associated with sore throat and enlarged painful cervical lymph nodes. These episodes recurred every 4 weeks and lasted for 3 to 7 days. Symptoms were accompanied by headache and occasionally enlarged inguinal lymph nodes. There was no history of aphthous stomatitis. She was symptom-free between the episodes, and her lymph nodes regressed to normal size. She had no family history of periodic fever syndromes and no Mediterranean ancestry. The physical examination was unremarkable at the time of initial evaluation. The complete blood count was unremarkable, including the absolute neutrophil count and normal inflammatory markers. Infectious workup was negative, including HIV, chronic hepatitis B and C, tuberculosis Quantiferon gold, gonorrhea/chlamydia, Bartonella, and Epstein-Barr Virus serologies. She had an inguinal lymph node biopsy, which was negative for any malignancies. The autoinflammatory genetic profile was negative. Autoimmune disease workup was also unremarkable, including negative antinuclear antibodies, antineutrophilic cytoplasmic antibodies, and rheumatoid arthritis serologies. She had a dramatic response to just 1 dose of prednisone 60 mg daily, with complete resolution of her symptoms during a flare. PFAPA syndrome was diagnosed based on her history and significant response to prednisone. She continued to have recurrent episodes, so she was started on colchicine 0.6 mg twice daily, which led to a significant decrease in the frequency of these inflammatory episodes, and she had just 1 flare in the first 6 months after starting colchicine.

Discussion

PFAPA syndrome is a periodic fever syndrome, and its prevalence is rare in adults, explaining the delay in diagnosis [3]. The etiopathogenesis is unknown, but it has polygenic inheritance as opposed to monogenic inheritance of familial Mediterranean fever [4,5]. It has a slight male preponderance [1]. Periodic fever is the hallmark feature, and episodes usually last 3 to 7 days and recur every 2 to 8 weeks [6]. Aphthous ulcers usually occur on the buccal mucosa or the lips in approximately 40% to 70% of patients [3]. Pharyngitis with tonsillar exudates and cervical adenopathy usually occur with fever episodes [7]. The clinical phenotype seems similar in the adult and pediatric populations, with some prominent differences [1]. Adults tend to have more arthralgia and myalgia during flares [1]. The frequency of flares is higher in children, whereas the fever duration is higher in adults [8]. The occurrence of only 1 cardinal manifestation is more frequent in adults [3]. The diagnosis is mostly clinical, as there are no specific biomarkers. Modified Marshall’s criteria (Table 1) proposed in 1999 have good sensitivity but lack specificity [1,9]. Our patient met these clinical criteria, and infectious causes were ruled out.

Differential diagnosis of PFAPA syndrome is broad, including infections, malignancies, systemic autoimmune diseases, and other autoinflammatory syndromes, such as familial Mediterranean fever. In our case, extensive infectious workup was negative, and the autoantibody profile was unremarkable. The patient did not have erysipelas-like rash or symptoms of serositis, which are cardinal features of familial Mediterranean fever, and FMF gene mutation was negative in the autoinflammatory panel.

Pediatric PFAPA syndrome is a self-limited disease with no long-term sequelae, although studies in adults are lacking [10–12]. Glucocorticoids are the first-line treatment, with symptoms improving within 24 h after a single dose of prednisone (1–2 mg/kg) [13] but cannot prevent subsequent fever flares [13]. There are multiple small studies on the use of colchicine in the pediatric population [10,14–16], but only limited evidence in the adult population [17–19]. It is postulated that there is upregulation of IL-1 beta in PFAPA syndrome, and colchicine acts through its inhibitory effect on the nucleotide-binding domain, leucine-rich repeat/pyrin domain-containing-3 inflammasome and IL-1 beta production [20]. Colchicine worked effectively in our case, with a substantial decrease in the number of flares, and we used 0.6 mg twice daily dosing as opposed to the dose used in other case reports [18]. IL-1 blockade with anakinra and canakinumab has been a recent development in PFAPA treatment, due to the association of elevated IL-1 beta-related transcripts during PFAPA flares [21–24]. Many studies support tonsillectomy with or without adenoidectomy in controlling symptoms or inducing remission, but attacks can recur after the surgery. Tonsillectomy seems less effective in adults than in children [25].

Conclusions

Adult-onset PFAPA syndrome is rare, and physicians are even less aware of it. It is a clinical diagnosis, but the lack of a 1 specific clinical feature should not preclude making the diagnosis if the clinical picture is otherwise highly suggestive of it. Colchicine has a potential prophylactic role, but larger studies are required for a definitive therapeutic assessment.

Table 1. Modified Marshall’s criteria.

Criteria set	Modified Marshall’s criteria	
Age at onset	<5 years	
Definition of “recurrent fever”	• Regularly recurring fevers	
Symptoms	≥1/3 Aphthous stomatitis

Cervical lymphadenitis

Pharyngitis

	
Inter-attack periods	Completely asymptomatic

Normal growth and development

	
Exclusions	Cyclic neutropenia

Upper respiratory tract infection

	

Publisher’s note: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher

Department and Institution Where Work Was Performed

Rheumatology Department, Saint Louis University School of Medicine, Saint Louis, MO, USA.
==== Refs
References:

1. Batu ED Periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome: Main features and an algorithm for clinical practice Rheumatol Int 2019 39 6 957 70 30798384
2. Yamahara K Egawa Y Lee K A case of adult-onset periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome responsive to tonsillectomy in Japan Case Rep Otolaryngol 2019 2019 1746180 31637075
3. Ferreira Cristina S Costa A Toscano M Periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis syndrome: A rare etiology of fever in adults Cureus 2021 13 4 e14749 34084676
4. Wekell P Karlsson A Berg S Fasth A Review of autoinflammatory diseases, with a special focus on periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis syndrome Acta Paediatr 2016 105 10 1140 51 27426283
5. Kraszewska-Głomba B Matkowska-Kocjan A Szenborn L The pathogenesis of periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis syndrome: A review of current research Mediators Inflamm 2015 2015 563876 26457006
6. Wang A Manthiram K Dedeoglu F Licameli GR Periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome: A review World J Otorhinolaryngol Head Neck Surg 2021 7 3 166 73 34430824
7. Ali NS Sartori-Valinotti JC Bruce AJ Periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome Clin Dermatol 2016 34 4 482 86 27343963
8. Rigante D Vitale A Natale MF A comprehensive comparison between pediatric and adult patients with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenopathy (PFAPA) syndrome Clin Rheumatol 2017 36 2 463 68 27251674
9. Thomas KT Feder HM Jr Lawton AR Periodic fever syndrome in children J Pediatr 1999 135 1 15 21 10393598
10. Padeh S Brezniak N Zemer D Periodic fever, aphthous stomatitis, pharyngitis, and adenopathy syndrome: Clinical characteristics and outcome J Pediatr 1999 135 1 98 101 10393612
11. Hofer M Pillet P Cochard MM International periodic fever, aphthous stomatitis, pharyngitis, cervical adenitis syndrome cohort: Description of distinct phenotypes in 301 patients Rheumatology (Oxford) 2014 53 6 1125 29 24505122
12. Wurster VM Carlucci JG Feder HM Jr Long-term follow-up of children with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis syndrome J Pediatr 2011 159 6 958 64 21798555
13. Gaggiano C Rigante D Sota J Treatment options for periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome in children and adults: A narrative review Clin Rheumatol 2019 38 1 11 17 30488366
14. Butbul Aviel Y Tatour S Gershoni Baruch R Colchicine as a therapeutic option in periodic fever, aphthous stomatitis, pharyngitis, cervical adenitis (PFAPA) syndrome Semin Arthritis Rheum 2016 45 4 471 74 26315860
15. Tasher D Stein M Dalal I Colchicine prophylaxis for frequent periodic fever, aphthous stomatitis, pharyngitis and adenitis episodes Acta Paediatr 2008 97 8 1090 92 18462461
16. Dusser P Hentgen V Neven B Is colchicine an effective treatment in periodic fever, aphtous stomatitis, pharyngitis, cervical adenitis (PFAPA) syndrome? Joint Bone Spine 2016 83 4 406 11 27068612
17. Gómez-Caverzaschi V Yagüe J Espinosa G Disease phenotypes in adult patients with suspected undifferentiated autoinflammatory diseases and PFAPA syndrome: Clinical and therapeutic implications Autoimmun Rev 2024 [Online ahead of print]
18. Ota K Kwak-Kim J Takahashi T Pregnancy complicated with PFAPA (periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis) syndrome: A case report BMC Pregnancy Childbirth 2018 18 1 207 29866074
19. Nozu T Ohhira M Ishioh M Adult-onset periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis syndrome responsive to colchicine Intern Med 2023 62 23 3555 58 37062730
20. Checchi V Maravic T Bellini P The role of matrix metalloproteinases in periodontal disease Int J Environ Res Public Health 2020 17 14 4923 32650590
21. Feder HM Salazar JC A clinical review of 105 patients with PFAPA (a periodic fever syndrome) Acta Paediatr 2010 99 2 178 84 19889105
22. Stojanov S Lapidus S Chitkara P Periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) is a disorder of innate immunity and Th1 activation responsive to IL-1 blockade Proc Natl Acad Sci USA 2011 108 17 7148 53 21478439
23. Sicignano LL Rigante D Moccaldi B Children and adults with PFAPA syndrome: Similarities and divergences in a real-life clinical setting Adv Ther 2021 38 2 1078 93 33315168
24. Yazgan H Gültekin E Yazıcılar O Comparison of conventional and low dose steroid in the treatment of PFAPA syndrome: Preliminary study Int J Pediatr Otorhinolaryngol 2012 76 11 1588 90 22858452
25. Padeh S Stoffman N Berkun Y Periodic fever accompanied by aphthous stomatitis, pharyngitis and cervical adenitis syndrome (PFAPA syndrome) in adults Isr Med Assoc J 2008 10 5 358 60 18605359
